# A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults

> **NCT01676675** · PHASE1 · WITHDRAWN · sponsor: **Jiangsu Province Centers for Disease Control and Prevention**

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** 7.5μg /0.5ml
- **BIOLOGICAL:** 15.0μg /0.5ml
- **BIOLOGICAL:** 30.0μg /0.5ml
- **BIOLOGICAL:** 0/0.5ml placebo

## Key facts

- **NCT ID:** NCT01676675
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-08
- **Primary completion:** 2013-01
- **Final completion:** 2013-03
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01676675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01676675, "A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01676675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*